Experimental antiviral drug to become the new standard of care for COVID-19 patients, Fauci says

April 29th, 20200 WASHINGTON, D.C. – Top U.S. infectious disease official Dr. Anthony Fauci said Gilead Science Inc.'s experimental antiviral drug remdesivir will become the new standard of care for COVID-19 after results from a key clinical trial released Wednesday showed it help patients recover more quickly from the illness caused by the...